A detailed history of Cyrus J. Lawrence, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cyrus J. Lawrence, LLC holds 1,868 shares of PFE stock, worth $53,443. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,868
Previous 3,034 38.43%
Holding current value
$53,443
Previous $84,000 38.1%
% of portfolio
0.01%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $29,453 - $34,513
-1,166 Reduced 38.43%
1,868 $52,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $21,404 - $25,019
-667 Reduced 18.02%
3,034 $100,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $5.96 Million - $6.9 Million
-165,128 Reduced 97.81%
3,701 $135,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $115,452 - $150,301
-2,931 Reduced 1.71%
168,829 $6.88 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $66,299 - $86,546
-1,588 Reduced 0.92%
171,760 $8.8 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $1.94 Million - $2.36 Million
-44,258 Reduced 20.34%
173,348 $7.59 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $76,727 - $90,975
-1,649 Reduced 0.75%
217,606 $11.4 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $10 Million - $12.4 Million
219,255 New
219,255 $11.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $161B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cyrus J. Lawrence, LLC Portfolio

Follow Cyrus J. Lawrence, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyrus J. Lawrence, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cyrus J. Lawrence, LLC with notifications on news.